Legal status · United Kingdom
Is Efinopegdutide legal in the United Kingdom?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Efinopegdutide is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Efinopegdutide in the United Kingdom at a glance
| Classification | Investigational, not licensed |
|---|---|
| MHRA approval status | Not approved by MHRA; investigational |
| Human studies cited | 3 of 3 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Efinopegdutide profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
Efinopegdutide is being studied in registered clinical trials but has not received MHRA marketing approval in the United Kingdom.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Efinopegdutide is
Beat semaglutide on liver fat in a randomised head to head, cutting it 72.7 percent against 42.3 percent, while the weight difference was not significant. Adding glucagon does something to the liver that GLP-1 alone does not.
Most dual agonists on this site pair GLP-1 with GIP. This one pairs it with glucagon, which sounds wrong to anyone who knows glucagon raises blood sugar, and the logic is worth following.
Mechanism: A co-agonist at the GLP-1 and glucagon receptors, built on a long-acting Fc-based scaffold. GLP-1 receptor agonism reduces food intake and improves glycaemic control in the usual way.
Regulatory history: Investigational. Not approved. Licensed to Merck, originally from Hanmi, and previously carried Johnson and Johnson and Hanmi identifiers.
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Efinopegdutide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Efinopegdutide in other countries
Frequently asked questions
Is Efinopegdutide legal in the United Kingdom?
No. Efinopegdutide is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Can I buy Efinopegdutide in the United Kingdom?
No approved product exists to buy. In the United Kingdom Efinopegdutide is classified as "Investigational, not licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Efinopegdutide MHRA approved?
No. In the United Kingdom Efinopegdutide is classified as "Investigational, not licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: Investigational. Not approved. Licensed to Merck, originally from Hanmi, and previously carried Johnson and Johnson and Hanmi identifiers.. On the evidence, 3 human studies are cited on its profile.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Efinopegdutide live on its compound profile.
Efinopegdutide profileThis page is general information about the regulatory status of Efinopegdutide in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.